n-methylscopolamine has been researched along with diprenorphine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bentley, MT; Webster, JM; Wojcikiewicz, RJ | 1 |
Bordayo, EZ; Fawcett, JR; Frey, WH; Lagalwar, S; Svitak, AL | 1 |
2 other study(ies) available for n-methylscopolamine and diprenorphine
Article | Year |
---|---|
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits ligand binding to certain G protein-coupled receptors.
Topics: Animals; Binding, Competitive; Cell Membrane; Cholecystokinin; Diprenorphine; Ethylenediamines; Humans; Ligands; N-Methylscopolamine; Rats; Receptors, G-Protein-Coupled; Tumor Cells, Cultured | 2003 |
Inhibition of ligand binding to G protein-coupled receptors by arachidonic acid.
Topics: Adrenergic beta-Antagonists; Animals; Arachidonic Acid; Dihydroalprenolol; Diprenorphine; Humans; Ligands; Molecular Structure; Muscarinic Antagonists; N-Methylscopolamine; Narcotic Antagonists; Parasympatholytics; Protein Binding; Protein Isoforms; Quinuclidinyl Benzilate; Radioligand Assay; Receptors, Adrenergic, beta-2; Receptors, G-Protein-Coupled; Receptors, Muscarinic; Receptors, Opioid, mu; Receptors, Serotonin; Serotonin | 2005 |